Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKazera Global Regulatory News (KZG)

Share Price Information for Kazera Global (KZG)

Share Price is delayed by 15 minutes
Get Live Data
0.95    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.10 (11.111%)
Market Cap: £10.48m
KZG Live PriceLast checked at - London Stock Exchange

Intraday Kazera Global Share Chart

Placing and issue of equity

25 Mar 2014 13:30

RNS Number : 1327D
Kennedy Ventures PLC
25 March 2014
 

Kennedy Ventures plc

 

Placing to raise a further £60,625 and issue of equity

 

Further to the announcement released earlier today, Kennedy Ventures plc ("Kennedy Ventures" or "the Company") is pleased to announce that it has raised a further £60,625 (before expenses) through the issue of 4,850,000 new ordinary shares ("Placing Shares") at a price of 1.25 pence per Placing Share in Kennedy Ventures (the "Placing") to certain Directors of the Company.

 

The Directors participation in the Placing is set out below:

 

Director

Placing Shares

Beneficial Interest post-Placing

Peter Redmond

1,320,000

1,320,000

1.86%

Colin Weinberg

1,810,000

1,960,000

2.76%

Chris Yates

1,720,000

1,810,500

2.55%

 

The Directors' participation in the Placing is a related party transaction under the AIM Rules for Companies. In the absence of an independent director, Cenkos Securities plc, the Company's nominated adviser, considers that the terms of the transaction are fair and reasonable insofar as the Company's shareholders are concerned.

 

Application has been made for 4,850,000 new Ordinary Shares, which will rank pari passu in all respects with the existing Ordinary Shares of the Company, to be admitted to trading on AIM ("Admission"). Admission is expected to be effective from 8.00 a.m. on 28 March 2014.

 

Further to the announcement released earlier today, and following Admission of the Placing Shares referred to above, Giles Clarke, Chairman of the Company remains interested in a total of 4,800,000 ordinary shares (representing 6.75% of the Company), Nick Harrison, a Director of the Company, remains interested in a total of 4,800,000 ordinary shares (representing 6.75% of the Company) and Westleigh Investments Holdings Limited (a company beneficially owned by Giles Clarke and Nick Harrison), holds 7,600,000 Ordinary shares, (representing 10.69% of the Company).

 

Following Admission of the Placing Shares the total issued share capital of the Company is 71,098,000 Ordinary Shares, each with voting rights.

 

The Company does not currently hold any shares in treasury. Accordingly, this figure of 71,098,000 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

 

For further information, please contact:

Kennedy Ventures plc

Peter Redmond, Director

+44 (0) 0207 580 7576

 

Cenkos Securities plc

Derrick Lee / Alan Stewart

+44 (0) 131 220 6939

 

Peterhouse Corporate Finance

John Levinson

+44 (0) 207 469 0935

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEZMGZFFKFGDZM
Date   Source Headline
22nd Jun 20267:00 amRNSDefinitive US$10.5M Settlement Re: Aftan
27th May 20267:00 amRNSInvestor Update via Investor Meet Company
26th May 20267:00 amRNSWHM Strategic Production Sharing Agreement
20th May 20263:33 pmRNSHolding(s) in Company
18th May 20267:00 amRNSStrategic Update in relation to Aftan
30th Apr 20264:25 pmRNSDirector Resignation and Update on Loan Facility
30th Apr 202612:18 pmRNSHolding(s) in Company
30th Apr 202610:14 amRNSFunding Update: Loan Facility Extension & Increase
29th Apr 202610:01 amRNSDirector/PDMR Shareholding
28th Apr 20265:29 pmRNSGrant of Share Options
27th Apr 20267:00 amRNSStrategic and Operational Update
17th Apr 20267:00 amRNSAppointment of Technical Director
7th Apr 20267:00 amRNSBoard Changes and Appointment of Directors
31st Mar 20267:00 amRNSInterim Results
11th Feb 20267:00 amRNSOperational Update
28th Jan 20261:02 pmRNSResult of AGM
26th Jan 202611:30 amRNSHolding(s) in Company
26th Jan 202611:29 amRNSHolding(s) in Company
23rd Jan 20269:47 amRNSHolding(s) in Company
30th Dec 20257:00 amRNSNotice of AGM
30th Dec 20257:00 amRNSNotice of AGM
23rd Dec 20251:00 pmRNSReplacement - Issue of Shares and Warrants
23rd Dec 20251:00 pmRNSReplacement - Issue of Shares and Warrants
23rd Dec 202510:15 amRNSIssue of Shares and Warrants
23rd Dec 202510:15 amRNSIssue of Shares and Warrants
12th Dec 20257:00 amRNSFinal Results and publication of Annual Report
5th Dec 20253:56 pmRNSHolding(s) in Company
4th Dec 20257:00 amRNSClosure of Retail Offer
27th Nov 20257:00 amRNSUpdate on Aftan
26th Nov 20257:00 amRNSInvestor Presentation Via Investor Meet Company
26th Nov 20257:00 amRNSAppointment of Corporate Broker
26th Nov 20257:00 amRNSRetail Offer
24th Nov 20252:28 pmRNSHolding(s) in Company
21st Nov 202511:57 amRNSHolding(s) in Company
18th Nov 202512:30 pmRNSPublication of Investor Presentation
14th Nov 202511:39 amRNSHolding(s) in Company
11th Nov 20254:36 pmRNSHolding(s) in Company
10th Nov 20257:00 amRNSSubscription to Raise £1.3 million
3rd Nov 20257:00 amRNSWithdrawal of 2A Mining Right Objection
28th Oct 202511:29 amRNSExtension of Loan Facility
13th Oct 20257:15 amRNSOperational Update
25th Sep 20257:00 amRNSOperational Update: Deep Blue Minerals
4th Sep 202510:44 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNSOperational Update: Deep Blue Minerals
28th Aug 20254:45 pmRNSExercise of Share Warrants, PDMR Dealings & TVR
3rd Jul 20257:00 amRNSOperational Update: Whale Head Minerals
13th Jun 202510:00 amRNSChange of Registered Office
27th May 202510:30 amRNSDirector/PDMR Shareholding
22nd May 202511:02 amRNSHolding(s) in Company
19th May 20253:12 pmRNSDirector/PDMR Shareholding and Holdings in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.